Anti-TNF-alpha treatments and obstructive symptoms in Crohn's Disease: A prospective study

Digestive and Liver Disease

Volumn 45, Issue 3, 2013, Pages 258-262

  Condino, Giovanna ^a   Calabrese, Emma ^a   Zorzi, Francesca ^a   Onali, Sara ^a   Lolli, Elisabetta ^a   De Biasio, Fabiola ^a   Ascolani, Marta ^a   Pallone, Francesco ^a   Biancone, Livia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Adalimumab; Crohn's Disease; Infliximab; Obstructions

Indexed keywords

ADALIMUMAB; INFLIXIMAB; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMALL INTESTINE; SMALL INTESTINE OBSTRUCTION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84875515581     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.10.009     Document Type: Article

References (38)

1. Van Dullemen H.M., van Deventer S.J., Hommes D.W., et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody. Gastroenterology 1995, 109:129-135.
2. Schnitzler F., Fidder H., Ferrante M., et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut 2009, 58:492-500.
3. Hanauer S.B., Sandborn W.J., Rutgeerts P., et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006, 130:323-333.
4. Sandborn W.J., Rutgeerts P., Enns R., et al. Adalimumab induction therapy or Crohn disease previously treated with infliximab: a randomized trial. Annals of Internal Medicine 2007, 146:829-838.
5. Colombel J.F., Loftus E.V., Tremaine W.J., et al. The safety profile of Infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004, 126:19-31.
6. Targan S.R., Hanauer S.B., van Deventer S.J., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease study group. New England Journal of Medicine 1997, 337:1029-1035.
7. Baert F.J., D'Haens G.R., Peeters M., et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999, 116:22-28.
8. D'Haens G., Van Deventer S., Van Hogezand R., et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999, 116:1029-1034.
9. Vasilopoulos S., Kugathasan S., Saeian K., et al. Intestinal strictures complicating initially successful infliximab treatment for luminal Crohn's disease. American Journal of Gastroenterology 2000, 95:A2503.
10. Toy L.S., Scherl E.J., Kornbluth A., et al. Complete bowel obstruction following initial response to infliximab therapy for Crohn's disease: a series of a newly described complication. Gastroenterology 2000, 118:A2974.
11. Lichtenstein G.R., Olson A., Travers S., et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease. American Journal of Gastroenterology 2006, 101:1030-1038.
12. Rieder F., Brenmoehl J., Leeb S., et al. Wound healing and fibrosis in intestinal disease. Gut 2007, 56:130-139.
13. Di Sabatino A., Pender S.L.F., Jackson C.L., et al. Functional modulation of Crohn's disease myofibroblasts by anti-TNF antibodies. Gastroenterology 2007, 133:137-149.
14. Pallotta N., Barberani F., Hassan N.A., et al. Effect of Infliximab on small bowel stenosis in patients with Crohn's disease. World Journal of Gastroenterology 2008, 14:1885-1890.
15. Travis S.P.L., Stange E.F., Lémann M., et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006, 55:16-35.
16. Best W.R., Becktel J.M., Singleton J.W., et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
17. Hanauer S.B., Feagan B.G., Lichtenstein G.R., et al. ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002, 359:1541-1549.
18. Colombel J.F., Sandborn W.J., Rutgeerts P., et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007, 132:52-65.
19. Calabrese E., La Seta F., Buccellato A., et al. Crohn's disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema. Inflammatory Bowel Diseases 2005, 11:139-145.
20. Pallotta N., Baccini F., Corazziari E. Contrast ultrasonography of the normal small bowel. Ultrasound in Medicine and Biology 1999, 25:1335-1340.
21. Pallotta N., Baccini F., Corazziari E. Small intestine contrast ultrasonography. Journal of Ultrasound in Medicine 2000, 19:21-26.
22. Gasche C., Moser G., Turetschek K., et al. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 1999, 44:112-117.
23. Maconi G., Bollani S., Bianchi Porro G. Ultrasonographic detection of intestinal complications in Crohn's disease. Digestive Diseases and Sciences 1996, 41:1643-1648.
24. Joseph A.E.A., Mcvicar D. Ultrasound in the diagnosis of abdominal abscesses. Clinical Radiology 1990, 42:154-156.
25. Arienti A., Zamboni L., Gionchetti P., et al. Ultrasonographic findings in Crohn's disease. Gut 2000, 46:293.
26. Rutgeerts P., Diamond R.H., Bala M., et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointestinal Endoscopy 2006, 63:433-442.
27. Lichtenstein G.R., Feagan B.G., Cohen D.H., et al. Serious infections and mortality in association with therapies for Crohn's Disease: TREAT Registry. Clinical Gastroenterology and Hepatology 2006, 4:621-630.
28. Hansen R.A., Gartlehner G., Powell G.E., et al. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clinical Gastroenterology and Hepatology 2007, 5:729-735.
29. Knapp A.B., Mirsky F.J., Dillon E.H., et al. Successful Infliximab therapy for a stricture caused by Crohn's Disease. Inflammatory Bowel Diseases 2005, 11:1123-1124.
30. Pelletier A.L., Kalisazan B., Wienckiewicz J., et al. Infliximab treatment for symptomatic Crohn's disease strictures. Alimentary Pharmacology and Therapeutics 2009, 29:279-285.
31. Miehsler W., Novacek G., Wenzl H., et al. A decade of Infliximab: the Austrian evidence based consensus on the safe use of Infliximab in inflammatory bowel disease. Journal of Crohn's and Colitis 2010, 4:221-256.
32. Holtmann M.H., Neurath M.F. Anti-TNF strategies in stenosing and fistulizing Crohn's disease. International Journal of Colorectal Disease 2005, 20:1-8.
33. Sorrentino D., Terrosu G., Vadalà S., et al. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease. Digestion 2007, 75:22-24.
34. Sorrentino D. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far?. Digestion 2008, 77:38-47.
35. Sorrentino D. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's Disease. American Journal of Gastroenterology 2006, 2892.
36. Louis E., Boverie J., Dewit O., et al. Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study. Acta Gastroenterologica Belgica 2007, 70:15-19.
37. Cosnes J., Cattan S., Blain A., et al. Long-term evolution of disease behaviour of Crohn's disease. Inflammatory Bowel Diseases 2002, 8:244-250.
38. Pallone F., Boirivant M., Stazi M.A., et al. Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum. Digestive Diseases and Sciences 1992, 37:215-219.